medvi semaglutide dosing GLP-1 Clinic Review: A Flat Rate With Options Semaglutide Dosage for Weight Loss

According to the UK product information, the most frequently reported adverse effects include: Nausea and diarrhoea very common (affecting at least 10% of patients) Vomiting, constipation and abdominal pain common (affecting between 1% and 10% of patients) Dyspepsia (indigestion) common (affecting between 1% and 10% of patients) Flatulence and bloating commonly reported but less frequently documented in trials These gastrointestinal effects are dose-dependent, meaning they tend to be more pronounced at higher doses (0.5-2mg)

In clinical trials, patients achieved an average of 14.9% body weight loss

PMID 1658407

p 7 kg and a BMI decrease of 2.8 kg/m